Targeted and immunotherapy Clinical Trials

1 actively recruiting trial

Top Sponsors

Peking University First Hospital1

Indications

Metastatic Renal Cancer1
Recurrent Renal Cell Cancer1
Radiation Therapy1
Cancer1

Other1 trial

SABR Combined With Targeted Therapy and Anti-PD-1 for Recurrent or Metastatic Renal Cancer

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.